Hydrochlorothiazide/Ramipril

氢氯噻嗪/雷米普利

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Ramipril
Drug Alias NameRamipril and Hydrochlorothiazide雷米普利/氢氯噻嗪Hydrochlorothiazide and RamiprilRamipril/HydrochlorothiazideTriatec HCT
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes HydrochlorothiazideRamipril
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA05
Related LinksN/A